Hint mode is switched on Switch off
For swift navigation between sections

Bellus Health
LEI 549300QZYQDSMOXCP667

PDF download

Choose all Reset all
Download Cancel
Organization name
Bellus Health Inc
Country name
Canada
Country of registration
Canada
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
13 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

BELLUS Health Inc. operates as a clinical-stage biopharmaceutical company. The Company develops drugs for rare diseases, including conditions that affect the kidneys, as well as treatments for sarcoidosis and hemolytic uremic syndrome.

Awards

Documentation

IFRS/US GAAP reports

2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300QZYQDSMOXCP667
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001259942
Registration is required to get access.